Your session is about to expire
← Back to Search
Tofacitinib for Lupus
Study Summary
This trial will study the effects of a new drug, TOFA, on young adults with lupus. The aim is to see if it is safe and effective. The trial will be conducted at two medical centers in Ohio.
- Lupus
- Cutaneous Lupus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 3 trial • 209 Patients • NCT02281552Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How can I sign up for this opportunity to participate in this research?
"This dermatology study is currently enrolling 20 patients who have cutaneous lupus and are aged between 18-45."
What are Tofacitinib's most popular indications?
"Tofacitinib is an effective medication for treating juvenile arthritis, even in patients who are unable to take methotrexate."
How many individuals are partaking in this experiment?
"The clinical trial is definitely recruiting patients if the information on clinicaltrials.gov is anything to go off of. The last update was on 7/15/2022 and 20 patients are needed between 2 sites."
Can you share any other studies that have been done using Tofacitinib?
"Tofacitinib is being trialled in 34 active clinical studies, 7 of which are Phase 3 trials. Most of the Tofacitinib research is based in Shanghai, but there are a total of 662 medical facilities running these tests across the world."
Are investigators still looking for test subjects?
"Yes, this page on clinicaltrials.gov shows that the trial is looking for participants. The listing was put up on 8/23/2017 and last updated on 7/15/2022."
Does this study have an age limit? If so, what is it?
"This particular trial is seeking out 18-45 year old patients. There are a total of 22 trials involving minors and 139 for senior citizens."
Share this study with friends
Copy Link
Messenger